key: cord-0816335-ukah6hok authors: Zou, Jingbo; Zhi, Shenshen; Chen, Mengyuan; Su, Xingyu; Kang, Ling; Li, Caiyu; Su, Xiaosong; Zhang, Shiyin; Ge, Shengxiang; Li, Wei title: Heat inactivation decreases the Qualitative Real-time RT-PCR detection rates of clinical samples with high Cycle Threshold Values in COVID-19 date: 2020-06-11 journal: Diagn Microbiol Infect Dis DOI: 10.1016/j.diagmicrobio.2020.115109 sha: 9af54a92de70ce12164d5b03e2eff4be101e026d doc_id: 816335 cord_uid: ukah6hok Abstract SARS-CoV-2 has caused COVID-19 pandemic globally in the beginning of 2020, and Qualitative Real-time RT-PCR has become the gold standard in diagnosis. As SARSCoV-2 with strong transmissibility and pathogenicity, it has become a professional consensus that clinical samples from suspected patients should be heat inactivated at 56°C for 30min before further processing. However, previous studies on the effect of inactivation on Qualitative Real-time RT-PCR were conducted with diluted samples rather than clinical samples. The aim of this study was to investigate whether heatinactivation on clinical samples before detection will affect the accuracy of Qualitative Real-time RT-PCR detection. All 46 throat swab samples from 46 confirmed inpatients were detected by Qualitative Real-time RT-PCR directly, as well as after heat inactivation. Heat-Inactivation has significantly influenced the qualitative detection results on clinical samples, especially weakly positive samples. The results indicate the urgency to establish a more suitable protocol for COVID-19 clinical sample's inactivation. Abstract SARS-CoV-2 has caused COVID-19 pandemic globally in the beginning of 2020, and Qualitative Real-time RT-PCR has become the gold standard in diagnosis. As SARSCoV-2 with strong transmissibility and pathogenicity, it has become a professional consensus that clinical samples from suspected patients should be heat inactivated at 56℃ for 30min before further processing. However, previous studies on the effect of inactivation on Qualitative Real-time RT-PCR were conducted with diluted samples rather than clinical samples. The aim of this study was to investigate whether heatinactivation on clinical samples before detection will affect the accuracy of Qualitative Real-time RT-PCR detection. All 46 throat swab samples from 46 confirmed inpatients were detected by Qualitative Real-time RT-PCR directly, as well as after heat inactivation. Heat-Inactivation has significantly influenced the qualitative detection results on clinical samples, especially weakly positive samples. The results indicate the urgency to establish a more suitable protocol for COVID-19 clinical sample's inactivation. Previous studies have different conclusions on whether sample inactivation reduces the detection rate of SARS-CoV-2, and only from using diluted samples. One study reported that samples diluted to low concentrations appeared false negative after treatment with different methods of inactivation (7) . By contraries, another study concluded that inactivation with high temperature or 75% ethanol had no effect on Qualitative Real-Time RT-PCR detection in 2 diluted samples (8) . As there was no published investigation on clinical samples without dilution, the influence caused by inactivation on detection rate of real-clinical samples was still unknown. This study is first to report on the effect of heat inactivation and reduced detection by Qualitative Real-Time RT-PCR using 46 COVID-19 clinical samples. The aim of this study was to investigate the influence of heat inactivation on COVID-19 samples at 56 °C for 30 minutes on the detection sensitivity of SARS-CoV-2 by Qualitative Real-Time RT-PCR. Between February 18th 2020 to February 23th 2020, 46 throat swab samples were According to Ct value of untreated group, samples were divided into 2 sub-groups of higher amount of virus (Ct<37) and lower amount of virus (Ct≥37) respectively. In higher amount of virus sub-group, the detection results of both gene of the inactivation group completely matched the outcomes of the untreated group, but some of them showed higher Ct values than their corresponding untreated samples. However, in lower amount of virus sub-groups, the N gene positive rates in inactivation and untreated group were 39.13% and 78.26% (P value was 0.003) separately, while 24.14% and 65.52% in ORF1ab gene (with P value of 0.001), means that inactivation lead to a large number of false negatives ( In early 2020, SARS-CoV-2 has caused global pandemics (9) . Various measures were implemented to prevent the outbreak, and accurate diagnosis was one of the forceful measures. Among pathogen diagnosis technologies, Qualitative Real-Time RT-PCR was used as the golden standard for patient confirmation. However, false negatives were common in newly infected patients and discharged patients who remained infectious (10), and this brought tremendous threaten to disease control and prevention. More efforts should be done to improve the accuracy of nucleic acid detection. Besides the reagents themselves and sampling sites, appropriate viral preservation mediums and inactivation methods played important roles in clinical nucleic acid testing. Two research teams had performed studies on diluted samples which were very different from clinical samples and drew opposite conclusions (7) (8) . More studies on both effective and mild inactivation conditions for SARS-CoV-2 should be conducted as this was a newly identified virus. To our knowledge, this is the first study performing such research with many clinical samples. The study indicated that heat inactivation treatment before detection A new coronavirus associated with human respiratory disease in China A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens Detection of SARS-CoV-2 in Different Types of Clinical Specimens Detection and analysis of nucleic acid in various biological samples of COVID-19 patients. Travel medicine and infectious disease The Experts' Consensus on Nucleic Acid Detection of 2019-nCoV The influence caused by inactivation treatment on weakly positive results of SARS-CoV-2 detectin The influence caused by different methods of sample inactivation on qPCR detection results of SARS-CoV-2 in throat swab samples None.